Loading…

High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome—A case–control study

Objective Patients with Sheehan syndrome (SS) are predisposed to coronary artery disease (CAD) due to risk factors like abdominal obesity, dyslipidemia and chronic inflammation. In addition to estimate CAD risk enhancers like high sensitive C reactive protein (hsCRP), apolipoprotein B (ApoB) and lip...

Full description

Saved in:
Bibliographic Details
Published in:Clinical endocrinology (Oxford) 2023-03, Vol.98 (3), p.375-382
Main Authors: Laway, Bashir Ahmad, Rasool, Abid, Baba, Mohammad Salem, Misgar, Raiz Ahmad, Bashir, Mir Iftikhar, Wani, Arshad Iqbal, Choh, Naseer, Shah, Omair, Lone, Ajaz, Shah, Zaffar
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3531-e5867280330d33f2ef3220eda395a38016134bc4648d546d940c3380aef62b233
cites cdi_FETCH-LOGICAL-c3531-e5867280330d33f2ef3220eda395a38016134bc4648d546d940c3380aef62b233
container_end_page 382
container_issue 3
container_start_page 375
container_title Clinical endocrinology (Oxford)
container_volume 98
creator Laway, Bashir Ahmad
Rasool, Abid
Baba, Mohammad Salem
Misgar, Raiz Ahmad
Bashir, Mir Iftikhar
Wani, Arshad Iqbal
Choh, Naseer
Shah, Omair
Lone, Ajaz
Shah, Zaffar
description Objective Patients with Sheehan syndrome (SS) are predisposed to coronary artery disease (CAD) due to risk factors like abdominal obesity, dyslipidemia and chronic inflammation. In addition to estimate CAD risk enhancers like high sensitive C reactive protein (hsCRP), apolipoprotein B (ApoB) and lipoprotein A [Lp(a)], this study applies Framingham risk score (FRS) and coronary artery calcium (CAC) score to compute a 10‐year probability of cardiovascular (CV) events in SS patients. Design Case–control study Sixty‐three SS patients, on a stable hormonal replacement treatment except for growth hormone and 65 age, body mass index and parity‐matched controls. Measurements Measurement of serum hsCRP, ApoB and Lp(a) and estimation of CAC with 16‐row multislice computed tomography scanner. Results The concentrations of hsCRP, ApoB and Lp(a) were significantly higher in SS patients than in controls (p  10) for incident CV events as against 1.6% controls. The mean Multi‐Ethnic Study of Atherosclerosis (MESA) score was significantly higher in patients with SS than controls. CAC corelated significantly with fasting blood glucose (r = .316), ApoB (r = .549), LP(a) (r = .310) and FRS (r = .294). Conclusion Significant number of asymptomatic SS patients have high coronary artery calcium score and are classified at risk for CAD.
doi_str_mv 10.1111/cen.14871
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2758353986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2758353986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3531-e5867280330d33f2ef3220eda395a38016134bc4648d546d940c3380aef62b233</originalsourceid><addsrcrecordid>eNp10cFuEzEQBmALgUgaOPACyBIXOGw6tne9m2MVFYIUwQE4rxx7ljhs7GDvUuXGO7SnPh5PwpQUDiB8Gcv6_I_lYeyZgLmgdW4xzEXZ1OIBmwqlq0JKXT1kU1AABWhdTthZzjsAqBqoH7MJGV2XQkzZ7cp_3vJDwm-mx2CRx47bmGIw6chNGpCKNb31nbdm8DFwExz3wSY0GR1PPn_hXUz_XHI-3wmi_EAXMQyZX_lhyz9sEbcm8HwMLsU9_vh-c0EtMm2ubQxDij3Pw-iOT9ijzvQZn97XGfv0-vLjclWs3795u7xYF1ZVShRYNbqWDSgFTqlOYqekBHRGLSqjGhBaqHJjS102riq1W5RgFZ0b7LTcSKVm7OUp95Di1xHz0O59ttj3JmAccyvrqqFOi0YTffEX3cUxBXodqboGkLUUpF6dlE0x54Rde0h-T3_TCmjvBtbSwNpfAyP7_D5x3OzR_ZG_J0Tg_ASufI_H_ye1y8t3p8if-6eimg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2777002721</pqid></control><display><type>article</type><title>High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome—A case–control study</title><source>Wiley</source><creator>Laway, Bashir Ahmad ; Rasool, Abid ; Baba, Mohammad Salem ; Misgar, Raiz Ahmad ; Bashir, Mir Iftikhar ; Wani, Arshad Iqbal ; Choh, Naseer ; Shah, Omair ; Lone, Ajaz ; Shah, Zaffar</creator><creatorcontrib>Laway, Bashir Ahmad ; Rasool, Abid ; Baba, Mohammad Salem ; Misgar, Raiz Ahmad ; Bashir, Mir Iftikhar ; Wani, Arshad Iqbal ; Choh, Naseer ; Shah, Omair ; Lone, Ajaz ; Shah, Zaffar</creatorcontrib><description>Objective Patients with Sheehan syndrome (SS) are predisposed to coronary artery disease (CAD) due to risk factors like abdominal obesity, dyslipidemia and chronic inflammation. In addition to estimate CAD risk enhancers like high sensitive C reactive protein (hsCRP), apolipoprotein B (ApoB) and lipoprotein A [Lp(a)], this study applies Framingham risk score (FRS) and coronary artery calcium (CAC) score to compute a 10‐year probability of cardiovascular (CV) events in SS patients. Design Case–control study Sixty‐three SS patients, on a stable hormonal replacement treatment except for growth hormone and 65 age, body mass index and parity‐matched controls. Measurements Measurement of serum hsCRP, ApoB and Lp(a) and estimation of CAC with 16‐row multislice computed tomography scanner. Results The concentrations of hsCRP, ApoB and Lp(a) were significantly higher in SS patients than in controls (p &lt; .01). After calculating FRS, 95.2% of SS patients were classified as low risk, 4.8% as intermediate risk and all controls were classified as low risk for probable CV events. CAC was detected in 50.7% SS patients and 7.6% controls (p = .006). According to the CAC score, 26.9% SS patients were classified as at risk (CAC &gt; 10) for incident CV events as against 1.6% controls. The mean Multi‐Ethnic Study of Atherosclerosis (MESA) score was significantly higher in patients with SS than controls. CAC corelated significantly with fasting blood glucose (r = .316), ApoB (r = .549), LP(a) (r = .310) and FRS (r = .294). Conclusion Significant number of asymptomatic SS patients have high coronary artery calcium score and are classified at risk for CAD.</description><identifier>ISSN: 0300-0664</identifier><identifier>EISSN: 1365-2265</identifier><identifier>DOI: 10.1111/cen.14871</identifier><identifier>PMID: 36567411</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>agatston score ; Apolipoprotein B ; Arteriosclerosis ; Body mass index ; C-reactive protein ; C-Reactive Protein - metabolism ; Calcification (ectopic) ; Calcium ; Cardiovascular disease ; Case-Control Studies ; Computed tomography ; coronary artery calcium ; Coronary artery disease ; Coronary Artery Disease - etiology ; Coronary Artery Disease - metabolism ; Coronary Vessels ; Dyslipidemia ; Framingham score ; Growth hormones ; Heart diseases ; Humans ; Hypopituitarism - complications ; panhypopituitarism ; Prevalence ; Risk Factors ; Sheehan syndrome ; Vascular Calcification - etiology ; Vascular Calcification - metabolism ; Vein &amp; artery diseases</subject><ispartof>Clinical endocrinology (Oxford), 2023-03, Vol.98 (3), p.375-382</ispartof><rights>2022 John Wiley &amp; Sons Ltd.</rights><rights>2023 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3531-e5867280330d33f2ef3220eda395a38016134bc4648d546d940c3380aef62b233</citedby><cites>FETCH-LOGICAL-c3531-e5867280330d33f2ef3220eda395a38016134bc4648d546d940c3380aef62b233</cites><orcidid>0000-0002-5437-2518 ; 0000-0003-1553-9407</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36567411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laway, Bashir Ahmad</creatorcontrib><creatorcontrib>Rasool, Abid</creatorcontrib><creatorcontrib>Baba, Mohammad Salem</creatorcontrib><creatorcontrib>Misgar, Raiz Ahmad</creatorcontrib><creatorcontrib>Bashir, Mir Iftikhar</creatorcontrib><creatorcontrib>Wani, Arshad Iqbal</creatorcontrib><creatorcontrib>Choh, Naseer</creatorcontrib><creatorcontrib>Shah, Omair</creatorcontrib><creatorcontrib>Lone, Ajaz</creatorcontrib><creatorcontrib>Shah, Zaffar</creatorcontrib><title>High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome—A case–control study</title><title>Clinical endocrinology (Oxford)</title><addtitle>Clin Endocrinol (Oxf)</addtitle><description>Objective Patients with Sheehan syndrome (SS) are predisposed to coronary artery disease (CAD) due to risk factors like abdominal obesity, dyslipidemia and chronic inflammation. In addition to estimate CAD risk enhancers like high sensitive C reactive protein (hsCRP), apolipoprotein B (ApoB) and lipoprotein A [Lp(a)], this study applies Framingham risk score (FRS) and coronary artery calcium (CAC) score to compute a 10‐year probability of cardiovascular (CV) events in SS patients. Design Case–control study Sixty‐three SS patients, on a stable hormonal replacement treatment except for growth hormone and 65 age, body mass index and parity‐matched controls. Measurements Measurement of serum hsCRP, ApoB and Lp(a) and estimation of CAC with 16‐row multislice computed tomography scanner. Results The concentrations of hsCRP, ApoB and Lp(a) were significantly higher in SS patients than in controls (p &lt; .01). After calculating FRS, 95.2% of SS patients were classified as low risk, 4.8% as intermediate risk and all controls were classified as low risk for probable CV events. CAC was detected in 50.7% SS patients and 7.6% controls (p = .006). According to the CAC score, 26.9% SS patients were classified as at risk (CAC &gt; 10) for incident CV events as against 1.6% controls. The mean Multi‐Ethnic Study of Atherosclerosis (MESA) score was significantly higher in patients with SS than controls. CAC corelated significantly with fasting blood glucose (r = .316), ApoB (r = .549), LP(a) (r = .310) and FRS (r = .294). Conclusion Significant number of asymptomatic SS patients have high coronary artery calcium score and are classified at risk for CAD.</description><subject>agatston score</subject><subject>Apolipoprotein B</subject><subject>Arteriosclerosis</subject><subject>Body mass index</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - metabolism</subject><subject>Calcification (ectopic)</subject><subject>Calcium</subject><subject>Cardiovascular disease</subject><subject>Case-Control Studies</subject><subject>Computed tomography</subject><subject>coronary artery calcium</subject><subject>Coronary artery disease</subject><subject>Coronary Artery Disease - etiology</subject><subject>Coronary Artery Disease - metabolism</subject><subject>Coronary Vessels</subject><subject>Dyslipidemia</subject><subject>Framingham score</subject><subject>Growth hormones</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>Hypopituitarism - complications</subject><subject>panhypopituitarism</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Sheehan syndrome</subject><subject>Vascular Calcification - etiology</subject><subject>Vascular Calcification - metabolism</subject><subject>Vein &amp; artery diseases</subject><issn>0300-0664</issn><issn>1365-2265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp10cFuEzEQBmALgUgaOPACyBIXOGw6tne9m2MVFYIUwQE4rxx7ljhs7GDvUuXGO7SnPh5PwpQUDiB8Gcv6_I_lYeyZgLmgdW4xzEXZ1OIBmwqlq0JKXT1kU1AABWhdTthZzjsAqBqoH7MJGV2XQkzZ7cp_3vJDwm-mx2CRx47bmGIw6chNGpCKNb31nbdm8DFwExz3wSY0GR1PPn_hXUz_XHI-3wmi_EAXMQyZX_lhyz9sEbcm8HwMLsU9_vh-c0EtMm2ubQxDij3Pw-iOT9ijzvQZn97XGfv0-vLjclWs3795u7xYF1ZVShRYNbqWDSgFTqlOYqekBHRGLSqjGhBaqHJjS102riq1W5RgFZ0b7LTcSKVm7OUp95Di1xHz0O59ttj3JmAccyvrqqFOi0YTffEX3cUxBXodqboGkLUUpF6dlE0x54Rde0h-T3_TCmjvBtbSwNpfAyP7_D5x3OzR_ZG_J0Tg_ASufI_H_ye1y8t3p8if-6eimg</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Laway, Bashir Ahmad</creator><creator>Rasool, Abid</creator><creator>Baba, Mohammad Salem</creator><creator>Misgar, Raiz Ahmad</creator><creator>Bashir, Mir Iftikhar</creator><creator>Wani, Arshad Iqbal</creator><creator>Choh, Naseer</creator><creator>Shah, Omair</creator><creator>Lone, Ajaz</creator><creator>Shah, Zaffar</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5437-2518</orcidid><orcidid>https://orcid.org/0000-0003-1553-9407</orcidid></search><sort><creationdate>202303</creationdate><title>High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome—A case–control study</title><author>Laway, Bashir Ahmad ; Rasool, Abid ; Baba, Mohammad Salem ; Misgar, Raiz Ahmad ; Bashir, Mir Iftikhar ; Wani, Arshad Iqbal ; Choh, Naseer ; Shah, Omair ; Lone, Ajaz ; Shah, Zaffar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3531-e5867280330d33f2ef3220eda395a38016134bc4648d546d940c3380aef62b233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>agatston score</topic><topic>Apolipoprotein B</topic><topic>Arteriosclerosis</topic><topic>Body mass index</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - metabolism</topic><topic>Calcification (ectopic)</topic><topic>Calcium</topic><topic>Cardiovascular disease</topic><topic>Case-Control Studies</topic><topic>Computed tomography</topic><topic>coronary artery calcium</topic><topic>Coronary artery disease</topic><topic>Coronary Artery Disease - etiology</topic><topic>Coronary Artery Disease - metabolism</topic><topic>Coronary Vessels</topic><topic>Dyslipidemia</topic><topic>Framingham score</topic><topic>Growth hormones</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>Hypopituitarism - complications</topic><topic>panhypopituitarism</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Sheehan syndrome</topic><topic>Vascular Calcification - etiology</topic><topic>Vascular Calcification - metabolism</topic><topic>Vein &amp; artery diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laway, Bashir Ahmad</creatorcontrib><creatorcontrib>Rasool, Abid</creatorcontrib><creatorcontrib>Baba, Mohammad Salem</creatorcontrib><creatorcontrib>Misgar, Raiz Ahmad</creatorcontrib><creatorcontrib>Bashir, Mir Iftikhar</creatorcontrib><creatorcontrib>Wani, Arshad Iqbal</creatorcontrib><creatorcontrib>Choh, Naseer</creatorcontrib><creatorcontrib>Shah, Omair</creatorcontrib><creatorcontrib>Lone, Ajaz</creatorcontrib><creatorcontrib>Shah, Zaffar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical endocrinology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laway, Bashir Ahmad</au><au>Rasool, Abid</au><au>Baba, Mohammad Salem</au><au>Misgar, Raiz Ahmad</au><au>Bashir, Mir Iftikhar</au><au>Wani, Arshad Iqbal</au><au>Choh, Naseer</au><au>Shah, Omair</au><au>Lone, Ajaz</au><au>Shah, Zaffar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome—A case–control study</atitle><jtitle>Clinical endocrinology (Oxford)</jtitle><addtitle>Clin Endocrinol (Oxf)</addtitle><date>2023-03</date><risdate>2023</risdate><volume>98</volume><issue>3</issue><spage>375</spage><epage>382</epage><pages>375-382</pages><issn>0300-0664</issn><eissn>1365-2265</eissn><abstract>Objective Patients with Sheehan syndrome (SS) are predisposed to coronary artery disease (CAD) due to risk factors like abdominal obesity, dyslipidemia and chronic inflammation. In addition to estimate CAD risk enhancers like high sensitive C reactive protein (hsCRP), apolipoprotein B (ApoB) and lipoprotein A [Lp(a)], this study applies Framingham risk score (FRS) and coronary artery calcium (CAC) score to compute a 10‐year probability of cardiovascular (CV) events in SS patients. Design Case–control study Sixty‐three SS patients, on a stable hormonal replacement treatment except for growth hormone and 65 age, body mass index and parity‐matched controls. Measurements Measurement of serum hsCRP, ApoB and Lp(a) and estimation of CAC with 16‐row multislice computed tomography scanner. Results The concentrations of hsCRP, ApoB and Lp(a) were significantly higher in SS patients than in controls (p &lt; .01). After calculating FRS, 95.2% of SS patients were classified as low risk, 4.8% as intermediate risk and all controls were classified as low risk for probable CV events. CAC was detected in 50.7% SS patients and 7.6% controls (p = .006). According to the CAC score, 26.9% SS patients were classified as at risk (CAC &gt; 10) for incident CV events as against 1.6% controls. The mean Multi‐Ethnic Study of Atherosclerosis (MESA) score was significantly higher in patients with SS than controls. CAC corelated significantly with fasting blood glucose (r = .316), ApoB (r = .549), LP(a) (r = .310) and FRS (r = .294). Conclusion Significant number of asymptomatic SS patients have high coronary artery calcium score and are classified at risk for CAD.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36567411</pmid><doi>10.1111/cen.14871</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5437-2518</orcidid><orcidid>https://orcid.org/0000-0003-1553-9407</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0300-0664
ispartof Clinical endocrinology (Oxford), 2023-03, Vol.98 (3), p.375-382
issn 0300-0664
1365-2265
language eng
recordid cdi_proquest_miscellaneous_2758353986
source Wiley
subjects agatston score
Apolipoprotein B
Arteriosclerosis
Body mass index
C-reactive protein
C-Reactive Protein - metabolism
Calcification (ectopic)
Calcium
Cardiovascular disease
Case-Control Studies
Computed tomography
coronary artery calcium
Coronary artery disease
Coronary Artery Disease - etiology
Coronary Artery Disease - metabolism
Coronary Vessels
Dyslipidemia
Framingham score
Growth hormones
Heart diseases
Humans
Hypopituitarism - complications
panhypopituitarism
Prevalence
Risk Factors
Sheehan syndrome
Vascular Calcification - etiology
Vascular Calcification - metabolism
Vein & artery diseases
title High prevalence of coronary artery calcification and increased risk for coronary artery disease in patients with Sheehan syndrome—A case–control study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T12%3A10%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20coronary%20artery%20calcification%20and%20increased%20risk%20for%20coronary%20artery%20disease%20in%20patients%20with%20Sheehan%20syndrome%E2%80%94A%20case%E2%80%93control%20study&rft.jtitle=Clinical%20endocrinology%20(Oxford)&rft.au=Laway,%20Bashir%20Ahmad&rft.date=2023-03&rft.volume=98&rft.issue=3&rft.spage=375&rft.epage=382&rft.pages=375-382&rft.issn=0300-0664&rft.eissn=1365-2265&rft_id=info:doi/10.1111/cen.14871&rft_dat=%3Cproquest_cross%3E2758353986%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3531-e5867280330d33f2ef3220eda395a38016134bc4648d546d940c3380aef62b233%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2777002721&rft_id=info:pmid/36567411&rfr_iscdi=true